Help change the future of PKU
Complete the form below and we will contact you as the site is updated. Increasing our knowledge of the neurological impact of phenylketonuria (PKU)—and its connection to clinical outcomes—may guide new approaches in management.1
We look forward to being a reliable source of relevant information about the impact of elevated phenylalanine (Phe) in PKU, as well as approaches to management and support tools.
Indicates required field
- Vockley J, Andersson HC, Antshel KM, et al; for American College of Medical Genetics and Genomics Therapeutic Committee. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014;16(2):188-190. doi:10.1038/gim.2013.157.